Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-01-22 @ 7:11 PM
Study NCT ID:
NCT00061633
Status:
COMPLETED
Last Update Posted:
2019-01-16
First Post:
2003-05-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
Sponsor:
Organization: